Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
MediaAlpha $59.6 million secondary offering
The stock is listed on the New York Stock Exchange
PAR Technology $200 million private placement
Proceeds from the offering will be used to partially fund the company’s acquisition of Stuzo Holdings
Avid Bioservices $160 million convertible senior notes offering
The convertible notes are due 2029
REGENXBIO $140 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Nestlé Capital $2.5 billion notes offering
The investment-grade notes are due 2029, 2031, 2034 and 2054
MicroStrategy $800 million convertible notes offering
The convertible notes are due 2030
Kosmos $400 million convertible notes offering and capped call transactions
The 3.125% convertible senior notes are due 2030
Hormel Foods $500 million notes offering
The investment-grade notes are due 2027
Albemarle $2.3 billion depositary share offering
The depositary shares represent an interest in the company’s 7.25% convertible preferred stock
Tyson Foods $1.5 billion senior notes offerings
We advised Tyson Foods on its investment-grade notes offering